Luye Pharma Group (OTCMKTS:LYPHF – Get Free Report) is expected to post its resultson Saturday, August 29th. Analysts expect Luye Pharma Group to announce earnings of $0.0074 per share and revenue of $465.3280 million for the quarter.
Luye Pharma Group Stock Performance
LYPHF opened at $0.27 on Friday. The business has a 50 day moving average price of $0.25 and a two-hundred day moving average price of $0.31. Luye Pharma Group has a 1-year low of $0.20 and a 1-year high of $0.33.
Luye Pharma Group Company Profile
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
Featured Stories
- Five stocks we like better than Luye Pharma Group
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
